Grundlæggende statistik
| LEI | 549300CP8NY40UP89Q40 |
| CIK | 1019600 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Future Metals NL
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| May 3, 2006 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2006 FRESENIUS MEDICAL CARE AG & Co. KGaA (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| May 3, 2006 |
Fresenius Medical Care Reports First Quarter 2006 Results; Excellent Start into the Year 2006 Exhibit 99.1 Investor News Fresenius Medical Care AG & Co. KGaA Investor Relations Else-Kröner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail : [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 3, 2006 Fresenius Medical Care Reports |
|
| February 9, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, iss |
|
| January 26, 2006 |
Filed pursuant to Rule 424(b)(3) Registration No. 333-128899 FRESENIUS MEDICAL CARE AG FRESENIUS MEDICAL CARE AG & Co. KGaA SUPPLEMENT DATED JANUARY 26 2006 TO PROSPECTUS DATED JANUARY 4, 2006 On January 5, 2006, we resolved to offer additional options to acquire up to 508,000 preference shares under our 2001 International Stock Incentive Plan. Such options will be subject to adjustment so that th |
|
| January 26, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, iss |
|
| January 6, 2006 |
Form of Election To Convert American Depositary Shares (ADSs) representing Fresenius Medical Care AG Preference Shares The undersigned hereby submits to Fresenius Medical Care AG, the preference share ADSs plus €3. |
|
| January 6, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| January 6, 2006 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-128899 PROSPECTUS U.S. CONVERSION OFFER Conversion Offer To U.S. holders of the non-voting preference shares without par value, including preference shares represented by American Depositary Shares, of Fresenius Medical Care AG We are offering holders of our non-voting preference shares, including preference shares represented |
|
| January 4, 2006 |
LETTER TO THE S.E.C. Baker & McKenzie LLP 1114 Avenue of the Americas New York, New York 10036, USA Tel: +1 212 626 4100 Fax: +1 212 310 1600 www.bakernet.com Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest |
|
| January 4, 2006 |
As filed with the Securities and Exchange Commission on January 4, 2006 As filed with the Securities and Exchange Commission on January 4, 2006 Registration No. |
|
| January 3, 2006 |
Fresenius Medical Care AG Else-Kröner Strasse 1 61352 Bad Homburg Germany Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg Germany January 3, 2006 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| December 30, 2005 |
Fresenius Medical Care AG Else-Kröner Strasse 1 61352 Bad Homburg Germany Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg Germany December 30, 2005 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| December 23, 2005 |
(BAKER & MCKENZIE LOGO) BAKER & MCKENZIE LLP 1114 Avenue of the Americas New York, New York 10036, USA Tel: +1 212 626 4100 Fax: +1 212 310 1600 www. |
|
| December 23, 2005 |
As filed with the Securities and Exchange Commission on December 23, 2005 F-4/A 1 y13273a2fv4za.htm AMENDMENT NO. 2 TO FORM F-4 Table of Contents As filed with the Securities and Exchange Commission on December 23, 2005 Registration No. 333-128899 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to Form F-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Fresenius Medical Care Aktiengesellschaft (Exact Name of Registrant as Specified in |
|
| December 23, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| November 17, 2005 |
EX-99.2: FORM OF EXCHANGE AGENT AGREEMENT Exhibit 99.2 EXCHANGE AGENT AGREEMENT , 200 JPMorgan Chase Bank, N.A. 4 New York Plaza New York, New York 10004 Attention: Tenders & Exchanges Dear Sirs: Fresenius Medical Care AG, a stock corporation organized under the laws of the Federal Republic Germany (“Fresenius”), proposes to make an offer (the “Offer”) to convert preference share American depositary shares (“ADSs”) (each preference share |
|
| November 17, 2005 |
As filed with the Securities and Exchange Commission on November 17, 2005 Table of Contents As filed with the Securities and Exchange Commission on November 17, 2005 Registration No. |
|
| November 17, 2005 |
EX-99.1: FORM OF LETTER OF TRANSMITTAL Exhibit 99.1 Form of Election To Convert American Depositary Shares (ADSs) representing Fresenius Medical Care AG Preference Shares The undersigned hereby submits to Fresenius Medical Care AG, the preference share ADSs plus €3.25 per preference share ADSs (the “Conversion Premium”), as indicated in box 3. The undersigned hereby also tenders $ per preference ADS tendered for conversion (the “US Pre |
|
| November 17, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| November 17, 2005 |
Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany CORRESP2 Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany November 17, 2005 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| November 17, 2005 |
CORRESP Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest Cairo Düsseldorf Frankfurt / Main Geneva Kyiv London Madrid Milan Moscow Munich Paris Prague Riyadh Rome St. |
|
| November 17, 2005 |
EX-12.1: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EX-12.1 Exhibit 12.1 For the nine months ending September 30, For the years ended December 31, 2005 2004 2004 2003 2002 Earnings/Fixed Charge Ratio 4.64 3.96 4.03 3.16 2.62 Earnings Add: Pre-tax income 568,303 487,563 668,599 545,676 468,450 Fixed Charges 155,414 163,954 219,573 251,318 284,135 Total additions 723,717 651,517 888,172 796,994 752,585 Less: Interest Capitalized 1,020 1,088 1,611 920 |
|
| November 3, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indica |
|
| November 3, 2005 |
EX-10.1 2 f01084exv10w1.htm EXHIBIT 10.1 Exhibit 10.1 AMENDMENT NO. 4 Dated as of October 20, 2005 to THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT Dated as of October 23, 2003 THIS AMENDMENT NO. 4 (this “Amendment”) dated as of October 20, 2005 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the “Transferor”), (ii) NATIONAL MEDICAL CARE, INC., |
|
| November 3, 2005 |
Exhibit 10.2 AMENDMENT Dated as of October 20, 2005 to RECEIVABLES PURCHASE AGREEMENT Dated as of August 28, 1997 THIS AMENDMENT (this ?Amendment?) dated as of October 20, 2005 is entered into by and between NMC FUNDING CORPORATION, a Delaware corporation, as Purchaser (the ?Purchaser?) and NATIONAL MEDICAL CARE, INC., a Delaware corporation, as Seller (the ?Seller?). PRELIMINARY STATEMENTS A. The |
|
| October 11, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| October 7, 2005 |
EX-99.3: CONSENT OF GARY A. BRUKARDT PURSUANT TO RULE 438 Exhibit 99.3 Consent of Gary A. Brukardt Pursuant to Rule 438 I hereby consent to being named in the within registration statement as a person designated to be appointed to the management board of Fresenius Medical Care Management AG, the general partner of Fresenius Medical Care AG & Co. KGaA, and to the references to me in said registration statement. /s/ Gary A. Brukardt Gary A. Brukardt Nashvi |
|
| October 7, 2005 |
As filed with the Securities and Exchange Commission on October 7, 2005 Table of Contents As filed with the Securities and Exchange Commission on October 7, 2005 Registration No. |
|
| August 5, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 5, 2005 |
Exhibit 10.1 ARTICLES OF ASSOCIATION OF FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT I. General Terms ARTICLE 1 Firm Name and Registered Office The Company is a stock corporation. The name of the Company is Fresenius Medical Care Aktiengesellschaft The registered office of the Company is in Hof an der Saale. ARTICLE 2 Purpose (1) The purpose of the Company is a) the development, production and distri |
|
| July 20, 2005 |
Table of Contents Prospectus Filed Pursuant to Rule 424(b)3 Registration No. 333-124759 INVITATION TO THE EXTRAORDINARY GENERAL MEETING ISIN: DE 0005785802 // Securities Identification Numbers 578 580 ISIN: DE 0005785836 // Securities Identification Numbers 578 583 ISIN: DE 000A0DRW61 // Securities Identification Numbers A0DRW6 ISIN: US 3580291066 // American Depositary Receipts Numbers 879 529 IS |
|
| July 19, 2005 |
corresp1 Baker & McKenzie LLP 805 Third Avenue New York, NY 10022, USA Tel: +1 212 751 5700 Fax: +1 212 759 9133 www. |
|
| July 19, 2005 |
As filed with the Securities and Exchange Commission on July 19, 2005 Table of Contents As filed with the Securities and Exchange Commission on July 19, 2005 Registration No. |
|
| July 19, 2005 |
Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany corresp2 Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany July 19, 2005 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| July 13, 2005 |
Exhibit 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ben J. Lipps, certify that: 1. I have reviewed this amended annual report on Form 20-F/A of Fresenius Medical Care Aktiengesellschaft (the ?Report?). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements m |
|
| July 13, 2005 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the amended Annual Report on Form 20-F/A of Fresenius Medical Care AG (the ?Company?) for the year ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned, Dr. Ben Lipps, Chief |
|
| July 13, 2005 |
exv12w2 Exhibit 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lawrence Rosen, certify that: 1. I have reviewed this amended annual report on Form 20-F/A of Fresenius Medical Care Aktiengesellschaft (the “Report”). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| July 13, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A Amendment No. 1 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A Amendment No. 1 o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 |
|
| July 11, 2005 |
Board of Management VIA EDGAR AND FAX (202) 772-9217 Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549 July 6, 2005 Re: Fresenius Medical Care Corporation Form 20-F for fiscal year ended December 31, 2004 File No. 1-14444 Dear Mr. Rosenberg, On behalf of Fresenius Medical Care AG (the |
|
| July 1, 2005 |
EX-99.1: VOTING INSTRUCTION CARD Exhibit 99.2 TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS (?ADRs?) REPRESENTING PREFERENCE SHARES OF FRESENIUS MEDICAL CARE AG (THE ?COMPANY?) CUSIP NUMBER 358029205 JPMorgan Chase Bank, N.A., Depositary (the ?Depositary?) has received advice that the Separate Meeting of Preference Shareholders (the ?Meeting?) will be held at the Germany, on , 2005, beginning at 10:00 a.m., for the pu |
|
| July 1, 2005 |
EX-99.1: VOTING INSTRUCTION CARD Exhibit 99.1 TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS (?ADRs?) REPRESENTING ORDINARY BEARER SHARES OF FRESENIUS MEDICAL CARE AG (THE ?COMPANY?) CUSIP NUMBER 358029106 JPMorgan Chase Bank, N.A., Depositary (the ?Depositary?) has received advice that the Extraordinary General Meeting (the ?Meeting?) of Shareholders will be held at Germany, on , 2005, beginning at 10:00 a.m., for the |
|
| July 1, 2005 |
RE: Fresenius Medical Care AG Registration Statement on Form F-4 File No. 333-124759 CORRESP Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest Cairo Düsseldorf Frankfurt / Main Geneva Kyiv London Madrid Milan Moscow July 1, 2005 VIA EDGAR AND FED EX Jeffrey P. |
|
| July 1, 2005 |
As filed with the Securities and Exchange Commission on July 1, 2005 Table of Contents As filed with the Securities and Exchange Commission on July 1, 2005 Registration No. |
|
| July 1, 2005 |
EX-4.3: FORM OF POOLING AGREEMENT Exhibit 4.3 FRESENIUS AKTIENGESELLSCHAFT ELSE-KR?NER STRASSE 1 61352 BAD HOMBURG v.d.H GERMANY , 2005 Mr. Walter L. Weisman Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg v.d.H. Germany Mr. John G. Kringel Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg v.d.H. Germany Gentlemen: We refer to (i) the Pooling Agreement dated as of September 27, 1996 (the ?Ordinary |
|
| June 16, 2005 |
Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest Cairo D?sseldorf Frankfurt / Main Geneva Kyiv London Madrid Milan Moscow Munich Paris Prague Riyadh Rome St. |
|
| June 16, 2005 |
Board of Management VIA EDGAR AND FAX (202) 772-9217 Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549 June 16, 2005 Re: Fresenius Medical Care Corporation Form 20-F for fiscal year ended December 31, 2004 File No. 1-14444 Dear Mr. Rosenberg, On behalf of Fresenius Medical Care AG (the |
|
| May 20, 2005 |
COVER Baker & McKenzie LLP 805 Third Avenue New York, NY 10022, USA Tel: +1 212 751 5700 Fax: +1 212 759 9133 www. |
|
| May 20, 2005 |
As filed with the Securities and Exchange Commission on May 20, 2005 Table of Contents As filed with the Securities and Exchange Commission on May 20, 2005 Registration No. |
|
| May 10, 2005 |
As filed with the Securities and Exchange Commission on May 10, 2005 Table of Contents As filed with the Securities and Exchange Commission on May 10, 2005 Registration No. |
|
| May 5, 2005 |
Exhibit 10.1 SECOND AMENDMENT TO SUBORDINATED LOAN NOTE By this Allonge (this ?Allonge?), to the Subordinated Loan Note dated as of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German corporation, in the maximum principal amount of $400,000,000 (as amended by an Allonge dated as of September 29, 2003, the ?Note?) the Borrowers and the Lender hereby agree as follows: 1. All |
|
| May 5, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| May 5, 2005 |
Exhibit 10.2 AMENDMENT NO. 3 Dated as of January 1, 2005 to THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT Dated as of October 23, 2003 THIS AMENDMENT NO. 3 (this ?Amendment?) dated as of January 1, 2005 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the ?Transferor?), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation, as collection agent |
|
| May 5, 2005 |
Exhibit 10.3 AGREEMENT Dated as of May 3, 2005, Among FRESENIUS MEDICAL CARE AG, FRESENIUS MEDICAL CARE HOLDINGS, INC. FLORENCE ACQUISITION, INC. And RENAL CARE GROUP, INC. TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 1 SECTION 1.02. Closing 1 SECTION 1.03. Effective Time 1 SECTION 1.04. Effects 1 SECTION 1.05. Certificate of Incorporation and By-laws 1 SECTION 1.06. Direct |
|
| May 4, 2005 |
Fresenius Medical Care Reports First Quarter 2005 Results; Solid Start into the Year 2005 Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 04, 2005 Fresenius Medical Care Reports F |
|
| May 4, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| May 4, 2005 |
Fresenius Medical Care to Acquire Renal Care Group, Inc. Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 04, 2005 Fresenius Medical Care to Acquir |
|
| May 4, 2005 |
WHERE YOU CAN FIND MORE INFORMATION Filed by Fresenius Medical Care Aktiengesellschaft pursuant to Rules 165 and 425 promulgated under the Securities Act of 1933, as amended This filing consists of an investor presentation and press release issued by Fresenius Medical Care AG on May 4, 2005 in connection with its announcement of a proposed conversion of its outstanding preference shares into ordinary shares and transformation of the legal form of Fresenius Medical Care AG. |
|
| May 4, 2005 |
FRESENIUS MEDICAL CARE CORP. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) |
|
| April 6, 2005 | ||
| March 1, 2005 |
EXHIBIT 2.28 SUPPLEMENTAL INDENTURE THIS SUPPLEMENTAL INDENTURE is dated as of December 23, 2004, by and among FRESENIUS MEDICAL CARE AG (the "Company"), a German stock corporation (Aktiengesellschaft), U.S. BANK NATIONAL ASSOCIATION, a national banking association, as successor trustee to STATE STREET BANK AND TRUST COMPANY, a Massachusetts chartered trust company, as trustee (the "Trustee"), FMC |
|
| March 1, 2005 |
EXHIBIT 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ben J. Lipps, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in li |
|
| March 1, 2005 |
EXHIBIT 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lawrence Rosen, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in |
|
| March 1, 2005 |
EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Supervisory Board and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany: We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft of our report dated February 11, 2004 with respect to the consolidated balance sheet |
|
| March 1, 2005 |
EXHIBIT 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Fresenius Medical Care AG (the "Company") for the year ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Dr. Ben Lipps, Chief Executive |
|
| March 1, 2005 |
EXHIBIT 2.27 SUPPLEMENTAL INDENTURE THIS SUPPLEMENTAL INDENTURE is dated as of December 23, 2004, by and among FRESENIUS MEDICAL CARE AG (the "Company"), a German stock corporation (Aktiengesellschaft), U.S. BANK NATIONAL ASSOCIATION, a national banking association, as successor trustee to STATE STREET BANK AND TRUST COMPANY, a Massachusetts chartered trust company, as trustee (the "Trustee"), FMC |
|
| March 1, 2005 |
EXHIBIT 2.37 AMENDMENT NO. 3 dated as of December 10, 2004 to AMENDED AND RESTATED CREDIT AGREEMENT dated as of February 21, 2003 among FRESENIUS MEDICAL CARE HOLDINGS, INC., a New York corporation, FRESENIUS MEDICAL CARE AG, a German corporation, and the other Borrowers and Guarantors identified therein, the Lenders identified therein, and BANK OF AMERICA, N.A., as Administrative Agent BANC OF AM |
|
| March 1, 2005 |
EXHIBIT 4.19 (AMGEN LOGO) AMENDED AND RESTATED FREESTANDING DIALYSIS CENTER AGREEMENT NO. 200308358 - - The undersigned hereby agree to amend and restate Freestanding Dialysis Center Agreement No. 200308358 (the "Agreement"), between Amgen USA Inc. ("Amgen"), a wholly-owned subsidiary of Amgen Inc., and National Medical Care, Inc., including all subsidiaries and affiliates that are at least fifty |
|
| March 1, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT |
|
| November 12, 2004 |
Table of Contents Exhibit 10.1 AMENDMENT NO. 2 Dated as of October 21, 2004 to THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT Dated as of October 23, 2003 THIS AMENDMENT NO. 2 (this ?Amendment?) dated as of October 21, 2004 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the ?Transferor?), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation, |
|
| November 12, 2004 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indica |
|
| October 27, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wh |
|
| October 27, 2004 |
Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com October 27, 2004 Bad Homburg, Germany ? Octob |
|
| September 30, 2004 |
Back to Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of September 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indi |
|
| September 30, 2004 |
Exhibit 10.1 AMENDMENT TO SUBORDINATED LOAN NOTE By this Allonge (this "ALLONGE"), to the Subordinated Loan Note dated as of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German corporation, in the maximum principal amount of $400,000,000 (the "NOTE") the Borrowers and the Lender hereby agree as follows: 1. All capitalized terms used herein without definition shall have the |
|
| August 11, 2004 |
Exhibit 10.1 AMENDMENT TO SUBORDINATED LOAN NOTE By this Allonge (this "ALLONGE"), to the Subordinated Loan Note dated as of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German corporation, in the maximum principal amount of $400,000,000 (the "NOTE") the Borrowers and the Lender hereby agree as follows: 1. All capitalized terms used herein without definition shall have the |
|
| August 11, 2004 |
Back to Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| May 12, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whethe |
|
| May 12, 2004 |
Exhibit 2.30 AMENDMENT NO. 1 DATED AS OF MARCH 31, 2004 TO THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT DATED AS OF OCTOBER 23, 2003 THIS AMENDMENT NO. 1 (this "Amendment") dated as of March 31, 2004 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the "Transferor"), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation, as collection agent ( |
|
| May 12, 2004 |
Exhibit 10.1 Published CUSIP Number: 35803CAA6 AMENDMENT NO. 2 DATED AS OF MAY 7, 2004 TO AMENDED AND RESTATED CREDIT AGREEMENT DATED AS OF FEBRUARY 21, 2003 AMONG FRESENIUS MEDICAL CARE HOLDINGS, INC., A NEW YORK CORPORATION, FRESENIUS MEDICAL CARE AG, A GERMAN CORPORATION, AND THE OTHER BORROWERS AND GUARANTORS IDENTIFIED THEREIN, THE LENDERS IDENTIFIED THEREIN, AND BANK OF AMERICA, N.A., AS ADM |
|
| May 6, 2004 |
Fresenius Medical Care reports First Quarter 2004 results; First quarter ahead of expectations Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 6, 2004 Fresenius Medical Care reports Fi |
|
| May 6, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whethe |
|
| April 14, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| April 14, 2004 |
Exhibit 99.3 Report of the Supervisory Board of Fresenius Medical Care Aktiengesellschaft for the Financial Year 2003 The Managing Board informed the Supervisory Board comprehensively, regularly and in good time about the progress of the business activities, the situation of the company and important business transactions. Additionally, the chairman of the Supervisory Board was informed by the Man |
|
| April 14, 2004 |
Supplemental Information As a foreign corporation, Fresenius Medical Care is not presently subject to the SEC?s Proxy Rules. |
|
| April 14, 2004 |
Exhibit 99.1 Agenda of the General Meeting FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT Hof an der Saale Invitation to the Ordinary General Meeting ? ISIN: DE 0005785802 // Securities Identification Numbers 578 580 ? ? ISIN: DE 0005785836 // Securities Identification Numbers 578 583 ? ? ISIN: DE 000A0AHS96 // Securities Identification Numbers A0AHS9 ? ? ISIN: US 3580291066 // American Depositary Rece |
|
| April 14, 2004 |
TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS ("ADRs") REPRESENTING ORDINARY BEARER SHARES OF FRESENIUS MEDICAL CARE AG (THE ?COMPANY?) CUSIP NUMBER 358029106 JPMorgan Chase Bank, Depositary (the ?Depositary?) has received advice that the Ordinary General Meeting (the ?Meeting?) of Shareholders will be held at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany, on Thursday, May 27, 2004, beginning at 10:00 a. |
|
| March 5, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| March 2, 2004 |
EXHIBIT 14.1 CONSENT OF INDEPENDENT AUDITORS To the Supervisory Board and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft of our report dated February 10, 2004 relating to the consolidated balance sheets of Fresenius Medical Care Ak |
|
| March 2, 2004 |
EXHIBIT 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ben J. Lipps, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in li |
|
| March 2, 2004 |
EXHIBIT 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Fresenius Medical Care AG (the "Company") for the year ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Dr. Ben Lipps, Chief Executive |
|
| March 2, 2004 |
EXHIBIT 2.29 - - THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT among PARADIGM FUNDING LLC, GIRO MULTI-FUNDING CORPORATION, ASSET ONE SECURITIZATION, LLC LIBERTY STREET FUNDING CORP. as Conduit Investors NMC FUNDING CORPORATION, as Transferor NATIONAL MEDICAL CARE, INC., as Collection Agent THE FINANCIAL INSTITUTIONS PARTIES HERETO, as Bank Investors BAYERISCHE LANDESBANK, NEW YO |
|
| March 2, 2004 |
EXHIBIT 4.19 AMGEN FREESTANDING DIALYSIS CENTER AGREEMENT This Agreement ("Agreement"), between Amgen USA Inc. ("Amgen"), a wholly-owned subsidiary of Amgen Inc., and National Medical Care, Inc., including all subsidiaries and affiliates that are at least fifty and one-tenth percent (50.10%) owned by National Medical Care, Inc. and listed on Appendix B, (collectively, "NMC"), sets forth the terms |
|
| March 2, 2004 |
EXHIBIT 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lawrence Rosen, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in |
|
| March 2, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT |
|
| March 2, 2004 |
EXHIBIT 11.1 FRESENIUS MEDICAL CARE CODE OF BUSINESS CONDUCT December 2003 . . . TABLE OF CONTENTS PAGE - Foreword.................................................... 1 Setting the Standard........................................ 2 Mission Statement and Core Values........................... 3 Fresenius Corporate Compliance Program...................... 4 Who is Covered............................ |
|
| November 14, 2003 |
6-K 1 f00647e6vk.htm FORM 6-K Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of princ |
|
| September 4, 2003 |
Fresenius Medical Care announces appointment of new Chief Financial Officer Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com September 4, 2003 Fresenius Medical Care anno |
|
| September 4, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of September 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indic |
|
| August 14, 2003 |
Exhibit 1.1 ARTICLES OF ASSOCIATION OF FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT I. General Terms Article 1 Firm Name and Registered Office The Company is a stock corporation. The name of the Company is Fresenius Medical Care Aktiengesellschaft The registered office of the Company is in Hof an der Saale. Article 2 Purpose (1) The purpose of the Company is a) the development, production and distrib |
|
| August 14, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 5, 2003 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whe |
|
| August 5, 2003 |
Fresenius Medical Care AG reports Second Quarter and Six Months Results 2003 EX-99.1 3 f00604exv99w1.htm EXHIBIT 99.1 Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kröner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com Augu |
|
| May 16, 2003 |
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of May, 2003 containing its unaudited financial statements as of and for three month period ending March 31, 2002 as submitted to the Securities and Exchange |
|
| May 16, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| May 16, 2003 |
Exhibit 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of May, 2003 containing its unaudited financial statements as of and for three month period ending March 31, 2003 as submitted to the Securities and Exchange |
|
| May 7, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| May 7, 2003 |
Fresenius Medical Care reports First Quarter 2003 results Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 7, 2003 Fresenius Medical Care reports Fi |
|
| April 8, 2003 |
SECURITIES AND EXCHANGE COMMISION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month April 2003 Fresenius Medical Care Corporation (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg v.d.H. Germany (Address of principal executive offices) Indicate by check mark wh |
|
| March 18, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2002 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT |
|
| March 18, 2003 |
Pages from Prospectus dated 20 July 2000 EXHIBIT 10.2 EXCERPT FROM PROSPECTUS DATED JULY 20, 2000 OF FRESENIUS MEDICAL CARE AG DESCRIPTION OF THE POOLING AGREEMENTS The following is a summary of the material provisions of the Ordinary shares pooling agreement, dated as of September 27, 1996 among Fresenius AG, our independent directors as agents of the minority holders of Ordinary shares, and us, and the Preference shares pooling agreeme |
|
| March 18, 2003 |
EX-10.1 3 f00517exv10w1.txt CONSENT OF KPMG EXHIBIT 10.1 CONSENT OF INDEPENDENT AUDITORS To the Supervisory Board and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft of our report dated February 21, 2003 relating to the consolidated |
|
| March 18, 2003 |
EX-10.4 6 f00517exv10w4.txt CERTIFICATION SCHEIDER EXHIBIT 10.4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Fresenius Medical Care AG (the "Company") on Form 20-F filed during the month of March, 2003 as submitted to the Securities and Exchange Commission on the date hereof (the "Repo |
|
| March 18, 2003 |
EX-10.3 5 f00517exv10w3.txt CERTIFICATION LIPPS EXHIBIT 10.3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Fresenius Medical Care AG (the "Company") on Form 20F filed during the month of March 2003 as submitted to the Securities and Exchange Commission on the date hereof (the "Report"), |
|
| March 7, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| February 25, 2003 |
Fresenius Medical Care reports Fourth Quarter and Full-Year 2002 results Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kröner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com February 25, 2003 Fresenius Medical Care repo |
|
| February 25, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indica |
|
| November 15, 2002 |
e6vk Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) I |
|
| November 15, 2002 |
Exhibit 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of November, 2002 containing its unaudited financial statements as of and for three and nine month periods ending September 30, 2002 as submitted to the Secur |
|
| November 15, 2002 |
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of November, 2002 containing its unaudited financial statements as of and for three and nine month periods ending September 30, 2002 as submitted to the Secur |
|
| August 15, 2002 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 15, 2002 |
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of August, 2002 containing its unaudited financial statements as of and for three and six month periods ending June 30, 2002 as submitted to the Securities an |
|
| August 15, 2002 |
Exhibit 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of August, 2002 containing its unaudited financial statements as of and for three and six month periods ending June 30, 2002 as submitted to the Securities an |
